Hite Christopher 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Hite Christopher（CIK 1814238）在 1 家公司共报告 16 笔 SEC Form 4 内部人交易（最近一笔 2026-09-24）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-09-24 | Royalty Pharma plc (RPRX) | EVP & Chairman, Partnering | 卖出 | 96,073 | $5.6M |
| 2026-09-24 | Royalty Pharma plc (RPRX) | EVP & Chairman, Partnering | 卖出 | 3,927 | $231,403 |
| 2026-08-19 | Royalty Pharma plc (RPRX) | EVP & Chairman, Partnering | 卖出 | 100,000 | $6.0M |
| 2026-08-19 | Royalty Pharma plc (RPRX) | EVP & Chairman, Partnering | 卖出 | 16,800 | $0 |
| 2026-08-07 | Royalty Pharma plc (RPRX) | EVP & Chairman, Partnering | 买入 | 11,002 | $0 |
| 2026-07-02 | Royalty Pharma plc (RPRX) | EVP & Chairman, Partnering | 卖出 | 97,446 | $5.5M |
| 2026-07-02 | Royalty Pharma plc (RPRX) | EVP & Chairman, Partnering | 卖出 | 2,554 | $145,841 |
| 2026-07-02 | Royalty Pharma plc (RPRX) | EVP & Chairman, Partnering | 卖出 | 29,400 | $1.7M |
| 2026-07-02 | Royalty Pharma plc (RPRX) | EVP & Chairman, Partnering | 卖出 | 600 | $34,254 |
| 2026-06-25 | Royalty Pharma plc (RPRX) | EVP & Chairman, Partnering | 卖出 | 32,408 | $1.8M |
| 2026-06-25 | Royalty Pharma plc (RPRX) | EVP & Chairman, Partnering | 卖出 | 117,592 | $6.4M |
| 2026-05-08 | Royalty Pharma plc (RPRX) | EVP & Vice Chairman | 买入 | 24,263 | $0 |
| 2026-02-13 | Royalty Pharma plc (RPRX) | EVP & Vice Chairman | 买入 | 26,626 | $0 |
| 2025-11-07 | Royalty Pharma plc (RPRX) | EVP & Vice Chairman | 买入 | 6,168 | $0 |
| 2025-08-08 | Royalty Pharma plc (RPRX) | EVP & Vice Chairman | 买入 | 3,696 | $0 |
| 2025-05-09 | Royalty Pharma plc (RPRX) | EVP & Vice Chairman | 买入 | 48,646 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-09-24